Canaan Inc.
CAN Nasdaq Finance Services Financials FY2019โFY2025
What Canaan Inc. does
No business description yet.
- Legal name
- Canaan Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Apr 15, 2026
- Accession ยท CIK
- 0001104659-26-043786
0001780652
Revenue and margins
Canaan Inc. had $530M of revenue in fiscal 2025, up 96.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$296M in fiscal 2025, โ55.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Canaan Inc. returned $5.0M to shareholders in fiscal 2025. The diluted share count rose 72.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Canaan Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $421M | $102M | $96.2M | $96.5M | $80.8M |
| Debt incl. finance leases | โ | โ | โ | $23.9M | $52.2M |
| Debt / equity | โ | โ | โ | 0.1x | 0.1x |
| Interest coverage | โ | โ | โ | โ436.0x | โ57.1x |
| Current ratio | 2.5x | 7.4x | 2.7x | 1.9x | 3.3x |
| Quick ratio | 2.1x | 4.6x | 1.6x | 1.3x | 1.9x |
| Total assets | $884M | $685M | $493M | $463M | $603M |
| Total liabilities | $341M | $77.3M | $145M | $197M | $166M |
| Shareholders' equity | $542M | $608M | $348M | $266M | $437M |
| Net debt (โ = net cash) | โ | โ | โ | โ$72.6M | โ$28.5M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 5 / 9 | 6 / 8 | 3 / 8 | 1 / 8 | 4 / 8 | 4 / 9 |
| Accruals ratio | โ76.1% | โ26.2% | 20.5% | 32.2% | โ49.3% | โ10.6% | 11.4% |
| Altman Z'' | โ | โ2.03 | 8.00 | 14.20 | โ1.49 | โ2.85 | 1.24 |
7 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $204M | $68.6M | $773M | $652M | $211M | $269M | $530M |
| Gross profit | โ$74.1M | $5.8M | $442M | $230M | โ$241M | โ$84.3M | $41.2M |
| Research and development | $24.3M | $21.5M | $52.2M | $81.8M | $64.8M | $61.3M | $63.1M |
| Operating income | โ | โ$38.9M | $283M | $42.9M | โ$411M | โ$227M | โ$112M |
| Interest expense | $2.9M | $0.6M | โ | โ | โ | $0.5M | $2.0M |
| Pretax income | โ$149M | โ$33.0M | $317M | $88.3M | โ$465M | โ$172M | โ$207M |
| Income tax | โ | $0.0M | $7.8M | $18.5M | โ$51.3M | $77.5M | $2.8M |
| Net income | โ$149M | โ$33.0M | $309M | $69.9M | โ$414M | โ$250M | โ$210M |
| Diluted EPS | โ$103.50 | โ$21.15 | $180.00 | $40.65 | โ$240.90 | โ$91.95 | โ$44.85 |
| Diluted shares | 0.14B | 0.16B | 0.17B | 0.17B | 0.17B | 0.27B | 0.47B |
| Cash flow | |||||||
| Cash from operations | โ$40.2M | $6.5M | $202M | โ$183M | โ$124M | โ$199M | โ$271M |
| Capital expenditure | $1.2M | $0.3M | $5.6M | $17.7M | $3.3M | $19.3M | $24.6M |
| Free cash flow | โ$41.4M | $6.1M | $197M | โ$200M | โ$127M | โ$219M | โ$296M |
| Stock-based compensation | $38.8M | $0.5M | $76.5M | $63.0M | $42.1M | $30.9M | $22.8M |
| Share buybacks | โ | $3.7M | $16.1M | $37.4M | โ | โ | $5.0M |
| Dividends and buybacks | โ | $3.7M | $16.1M | $37.4M | โ | โ | $5.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $75.8M | $69.5M | $421M | $102M | $96.2M | $96.5M | $80.8M |
| Total debt | $14.4M | $5.3M | โ | โ | โ | $23.9M | $52.2M |
| Current assets | $135M | $154M | $828M | $556M | $364M | $334M | $433M |
| Current liabilities | $41.0M | $90.8M | $327M | $75.3M | $135M | $179M | $131M |
| Inventory | $28.2M | $34.6M | $127M | $212M | $142M | $94.6M | $181M |
| Property and equipment, net | $3.2M | $1.9M | $29.1M | $85.4M | $29.5M | $40.2M | $44.0M |
| Intangible assets | โ | โ | โ | โ | โ | $0.9M | $0.7M |
| Total assets | $142M | $159M | $884M | $685M | $493M | $463M | $603M |
| Total liabilities | $42.9M | $92.5M | $341M | $77.3M | $145M | $197M | $166M |
| Shareholders' equity | $99.5M | $66.3M | $542M | $608M | $348M | $266M | $437M |
| Margins | |||||||
| Gross margin | โ36.3% | 8.4% | 57.2% | 35.3% | โ113.9% | โ31.3% | 7.8% |
| Operating margin | โ | โ56.7% | 36.6% | 6.6% | โ194.3% | โ84.3% | โ21.2% |
| Net margin | โ72.7% | โ48.0% | 40.0% | 10.7% | โ195.8% | โ92.7% | โ39.7% |
| FCF margin | โ20.3% | 9.0% | 25.4% | โ30.8% | โ60.0% | โ81.2% | โ55.8% |
| Returns | |||||||
| Return on capital | โ | โ1,471.4% | โ | โ | โ | โ92.6% | โ21.7% |
| Return on capital employed | โ | โ57.2% | 50.8% | 7.0% | โ114.7% | โ79.9% | โ23.8% |
| Return on equity | โ149.3% | โ39.8% | 101.5% | 12.2% | โ86.7% | โ81.3% | โ59.8% |
| Return on assets | โ104.3% | โ21.9% | 59.3% | 8.9% | โ70.3% | โ52.2% | โ39.5% |
| Return on tangible equity | โ149.3% | โ49.7% | 57.0% | 11.5% | โ118.9% | โ94.1% | โ48.2% |
| Growth | |||||||
| Revenue growth | โ | โ66.4% | 1,026.3% | โ15.7% | โ67.5% | 27.4% | 96.7% |
| Net income growth | โ | โ | โ | โ77.4% | โ692.6% | โ | โ |
| EPS growth | โ | โ | โ | โ77.4% | โ692.6% | โ | โ |
| FCF growth | โ | โ | 3,098.4% | โ201.9% | โ | โ | โ |
| Share count change | โ | 8.9% | 9.8% | 0.1% | 0.1% | 57.9% | 72.9% |
| Financial health | |||||||
| Debt / equity | 0.1x | 0.1x | โ | โ | โ | 0.1x | 0.1x |
| Interest coverage | โ | โ70.7x | โ | โ | โ | โ436.0x | โ57.1x |
| Current ratio | 3.3x | 1.7x | 2.5x | 7.4x | 2.7x | 1.9x | 3.3x |
| Quick ratio | 2.6x | 1.3x | 2.1x | 4.6x | 1.6x | 1.3x | 1.9x |
| Capital allocation | |||||||
| Capex / revenue | 0.6% | 0.5% | 0.7% | 2.7% | 1.6% | 7.2% | 4.6% |
| Stock comp / revenue | 19.0% | 0.7% | 9.9% | 9.7% | 19.9% | 11.5% | 4.3% |
| Payouts / FCF | โ | 59.6% | 8.2% | โ | โ | โ | โ |
| Quality scores | |||||||
| Piotroski F-score | โ | 5.0 | 6.0 | 3.0 | 1.0 | 4.0 | 4.0 |
| Altman Z'' | โ | โ2.0 | 8.0 | 14.2 | โ1.5 | โ2.8 | 1.2 |
| Accruals ratio | โ76.1% | โ26.2% | 20.5% | 32.2% | โ49.3% | โ10.6% | 11.4% |
Source: SEC EDGAR XBRL filings (CIK 0001780652). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Per-share figures are per US-listed share (1 ADS = 15 ordinary shares). For information only โ not investment advice. Check the original filings before relying on any figure.
